FAQ/Help |
Calendar |
Search |
Today's Posts |
|
ALS News & Research For postings of news or research links and articles related to ALS |
Reply |
|
Thread Tools | Display Modes |
11-02-2016, 08:58 AM | #1 | |||
|
||||
Grand Magnate
|
MediciNova Announces MN-166 (ibudilast) ALS Abstract Accepted for Presentation at the 27th International Symposium on ALS/MND in Dublin, Ireland
https://globenewswire.com/news-release/2016/10/30/884427/0/en/MediciNova-Announces-MN-166-ibudilast-ALS-Abstract-Accepted-for-Presentation-at-the-27th-International-Symposium-on-ALS-MND-in-Dublin-Ireland.html |
|||
Reply With Quote |
11-10-2016, 08:52 AM | #2 | |||
|
||||
Grand Magnate
|
Medicinova (MNOV) Receives Positive CHMP Opinion on Ibudilast as ALS Treatment
Medicinova (MNOV) Receives Positive CHMP Opinion on Ibudilast as ALS Treatment |
|||
Reply With Quote |
11-10-2016, 08:53 AM | #3 | |||
|
||||
Grand Magnate
|
MediciNova Announces European Medicines Agency Recommends Orphan Medicinal Product Designation for MN-166 (ibudilast) for Amyotrophic Lateral Sclerosis
http://www.nasdaq.com/press-release/...20161110-00207 |
|||
Reply With Quote |
11-16-2016, 12:54 PM | #4 | |||
|
||||
Grand Magnate
|
EU Panel Recommends Orphan Drug Status for Ibudilast for ALS Treatment
EU Panel Recommends Orphan Drug Status for ALS Therapy Ibudilast |
|||
Reply With Quote |
Reply |
|
|
Similar Threads | ||||
Thread | Forum | |||
MediciNova Announces FDA Granted Orphan Drug Designation to MN-166 (ibudilast) for Am | ALS News & Research | |||
NeuroDerm Announces Presentation of ND0612 Phase 1 and Phase 2 Results at the 2013 In | Parkinson's Disease | |||
Oxford BioMedica Announces Presentation of New Clinical Data From ProSavin(R) Phase I | Parkinson's Disease |